Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenruo Hu
Institution:
Sanofi (China)
Observed institution:
Sanofi (China)
OpenAlex ID:
A5066528906
Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial
2021
·
Tanuja Chitnis
, Brenda Banwell
, et al.
·
The Lancet Neurology
·
83
Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS
2024
·
Tanuja Chitnis
, Brenda Banwell
, et al.
·
Multiple Sclerosis Journal
·
15
PDF
Safety, efficacy, and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study
2024
·
Tanuja Chitnis
, Douglas L Arnold
, et al.
·
Multiple Sclerosis Journal
·
10
PDF
Reduced Doses of Factor Concentrates and Bypassing Agents to Treat Breakthrough Bleeds in Patients with Hemophilia A and B on Fitusiran Antithrombin-Based Dosing Regimen: ATLAS-OLE
2024
·
Steven W. Pipe
, Kaan Kavakli
, et al.
·
Blood
·
3
PDF
Sustained Improvement in Health-Related Quality of Life in Patients with Hemophilia A with or without Inhibitors Treated with Fitusiran Prophylaxis
2021
·
Viridiana Cano
, José Bartelt-Hofer
, et al.
·
Blood
·
1
Genome-wide gene-smoking interaction of Systolic andDiastolic blood pressure among Caucasians
2013
·
Wenruo Hu
Show more works
View as search
Works count:
6
Citation count:
112
H-index:
3
I10-index:
3
Year
Topic
Type
